Frédéric Triebel

Frederic Triebel has extensive experience in immunology and cancer research, holding positions such as CSO and CMO at various companies. Frederic has also worked as a Professor of Immunology and Head of Cellular Immunology at different institutions. Triebel has been involved in Phase I/II clinical trials and immunomonitoring in cancer patients, focusing on cancer vaccines, immunotherapy, and gene therapy. Frederic is a cancer immunologist with a M.D., Ph.D in Medicine, Clinical Haematology, and Immunology from Pierre and Marie Curie University.